Login / Signup

Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Katarzyna GęcaJakub LitwińskiTomasz OstrowskiIzabela ŚwietlickaWojciech P PolkowskiMagdalena Skórzewska
Published in: Cancers (2024)
The key factors enhancing ROC patients' survival include radical surgery, optimal performance status, platinum sensitivity, a positive AGO score, and a lower PCI. This study highlights the predictive value of the platinum resistance and AGO score in patient outcomes, underlining their role in treatment planning. Further prospective research is needed to confirm these results and improve patient selection for this treatment approach.
Keyphrases